REFERENCES
- Hardison RC, Chui DHK, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–233 (http://globin.cse.psu.edu).
- Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537-D541 (http://globin.cse.psu.edu).
- Peixeiro I, Silva AL, Romao L. Control of the human β-globin mRNA stability and its impact on β-thalassemia phenotype. Haematologica. 2011;96(6):905–913.
- Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. 1989:280–281.
- Petrakis NL, Doherty MA, Grunum BW, Atchley WA. Cellulose acetate membranes for the electrophoretic demonstration of Hemoglobin A2. Acta Haematol. 1962;27:96–103.
- Gottfried EL, Robertson NA. Glycerol lysis time as a screening for erythrocyte disorders. J Lab Clin Med. 1974;83(2):323–333.
- Kabnick KS, Housman DE. Determinants that contribute to cytoplasmic stability of human c-fos and β-globin mRNAs are located at several sites in each mRNA. Molec Cell Biol. 1988;8(8):3244–3250.
- Shyu AB, Greenberg ME, Belasco JG. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Develop. 1989;3(1):60–72.
- Wisdom R, Lee W. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Develop. 1991;5(2);232–243.
- Jiang Y, Xu XS, Russell JE. A nucleolin-binding 3′ untranslated region element stabilizes β-globin mRNA in vivo. Molec Cell Biol. 2006;26(6):2419–2429.
- Millevoi S, Decorsière A, Loulergue C, A physical and functional link between splicing factors promotes pre-mRNA 3′ end processing. Nucleic Acids Res. 2009;37(14):4672–4683.
- Millevoi S, Vagner S. Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation. Nucleic Acids Res. 2010;38(9):2757–2774.
- Yanagiya A, Svitkin YV, Shibata S, Mikami S, Imataka H, Sonenberg N. Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA Cap. Molec Cell Biol. 2009;29(6):1661–1669.
- Irenge LM, Robert A, Gala JL. Quantitative assessment of the transcriptional impact of mutations in the 3′ untranslated region of the human β-globin gene: application to the +1480 C>G mutation. Haematologica. 2006;91(11):1563–1564.
- Başak AN, Ozer A, Kirdar B, Akar N. A novel 13 bp deletion in the 3′UTR of the β-globin gene causes β-thalassemia in a Turkish patient. Hemoglobin. 1993;17(6):551–555.
- Bilenoglu O, Başak AN, Russell JE. A 3′UTR mutation affects β-globin expression without altering the stability of its fully processed mRNA. Br J Haematol. 2002;119(4):1106–1114.
- Irenge LM, Heusterspreute M, Philippe M, Derclaye I, Robert A, Gala JL. Validation of a recombinant DNA construct (micro LCR and full-length β-globin gene) for quantification of human β-globin expression: application to mutations in the promoter, intronic, and 5′- and 3′-untranslated regions of the human β-globin gene. Clin Chem. 2002;48(10):1787–1791.
- Cai SP, Eng B, Francombe WH, Two novel β-thalassemia mutations in the 5′ and 3′ noncoding regions of the β-globin gene. Blood. 1992;79(5):1342–1346.
- Bilgen T, Canatan D, Arıkan Y, Yeşilipek A, Keser İ. The effect of HBB:c.*+96T>C (3′UTR+1570T>C) on mild β-thalassemia intermedia phenotype. Turk J Hematol. 2011;28:219–222.